1. Home
  2. CVKD vs SQFT Comparison

CVKD vs SQFT Comparison

Compare CVKD & SQFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CVKD
  • SQFT
  • Stock Information
  • Founded
  • CVKD 2022
  • SQFT 1999
  • Country
  • CVKD United States
  • SQFT United States
  • Employees
  • CVKD N/A
  • SQFT N/A
  • Industry
  • CVKD Medicinal Chemicals and Botanical Products
  • SQFT Real Estate Investment Trusts
  • Sector
  • CVKD Health Care
  • SQFT Real Estate
  • Exchange
  • CVKD Nasdaq
  • SQFT Nasdaq
  • Market Cap
  • CVKD 17.1M
  • SQFT 9.5M
  • IPO Year
  • CVKD 2023
  • SQFT 2020
  • Fundamental
  • Price
  • CVKD $15.24
  • SQFT $0.68
  • Analyst Decision
  • CVKD Strong Buy
  • SQFT
  • Analyst Count
  • CVKD 2
  • SQFT 0
  • Target Price
  • CVKD $52.50
  • SQFT N/A
  • AVG Volume (30 Days)
  • CVKD 59.6K
  • SQFT 28.7K
  • Earning Date
  • CVKD 11-08-2024
  • SQFT 11-12-2024
  • Dividend Yield
  • CVKD N/A
  • SQFT 13.43%
  • EPS Growth
  • CVKD N/A
  • SQFT N/A
  • EPS
  • CVKD N/A
  • SQFT N/A
  • Revenue
  • CVKD N/A
  • SQFT $18,346,853.00
  • Revenue This Year
  • CVKD N/A
  • SQFT N/A
  • Revenue Next Year
  • CVKD N/A
  • SQFT N/A
  • P/E Ratio
  • CVKD N/A
  • SQFT N/A
  • Revenue Growth
  • CVKD N/A
  • SQFT 4.63
  • 52 Week Low
  • CVKD $5.40
  • SQFT $0.50
  • 52 Week High
  • CVKD $32.55
  • SQFT $1.45
  • Technical
  • Relative Strength Index (RSI)
  • CVKD 60.90
  • SQFT 49.34
  • Support Level
  • CVKD $11.19
  • SQFT $0.61
  • Resistance Level
  • CVKD $15.93
  • SQFT $0.73
  • Average True Range (ATR)
  • CVKD 1.36
  • SQFT 0.06
  • MACD
  • CVKD 0.23
  • SQFT -0.00
  • Stochastic Oscillator
  • CVKD 61.01
  • SQFT 58.33

About CVKD Cadrenal Therapeutics Inc.

Cadrenal Therapeutics Inc is focused on developing a novel therapy with orphan drug indication, tecarfarin, for the prevention of systemic thromboembolism (blood clots) of cardiac origin in patients with end-stage renal disease (on dialysis) and atrial fibrillation (irregular heartbeat) or AFib. Tecarfarin is an anticoagulant designed using a drug design process that targets a different pathway than most commonly prescribed drugs for the treatment of thrombosis and AFib.

About SQFT Presidio Property Trust Inc.

Presidio Property Trust Inc is an internally managed, diversified REIT with holdings in model home properties which are triple-net leased to homebuilders, office, industrial, and retail properties. Presidio's model homes are leased to homebuilders located in Arizona, Illinois, Texas, Wisconsin, and Florida. The office, industrial and retail properties are located primarily in Colorado, with properties also located in Maryland, North Dakota, Texas, and Southern California.

Share on Social Networks: